LaserSight Notified of U.S. Patent on Ex-Calibur(TM).ORLANDO, Fla.--(BUSINESS WIRE)--June 2, 1995--LaserSight (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :LASE) announced today that it has been notified by the U.S. Patent office that it will receive a patent on its unique calibration system for excimer lasers: Ex-Calibur(TM). The Ex-Calibur(TM) system uses a single-use, disposable target that is analyzed before and after a test ablation to fully characterize the laser's performance. It is the only system that offers pre-treatment confirmation of the desired ablation profile. LaserSight has not established a selling price for the disposable, but it is estimated to be $25.00 - $50.00 each. "The system can be used with any laser for PRK PRK photorefractive keratectomy. Photorefractive keratectomy (PRK) A procedure that uses an excimer laser to make modifications to the cornea and permanently correct myopia. (Photorefractive Keratectomy Photorefractive keratectomy (PRK) A procedure that uses an excimer laser to make modifications to the cornea and permanently correct myopia. Mentioned in: Myopia, Radial Keratotomy photorefractive keratectomy ). It can document centration, asphericity, multizone anatomy, astigmatic a·stig·ma·tism n. A visual defect in which the unequal curvature of one or more refractive surfaces of the eye, usually the cornea, prevents light rays from focusing clearly at one point on the retina, resulting in blurred vision. magnitude and direction, full correction size, ablation grade, and the presence or absence of beam irregularities such as cold spots." Said Robert Qualls, Chief Executive Officer of LaserSight Technology, Inc., "It provides indispensable information for the performance of PRK." CONTACT: LaserSight Inc. Robert Qualls, Chief Executive Officer 803/768-3505 or Gregory L. Wilson, Chief Financial Officer 314/469-3220 or Marti Benfield, Investor Relations Investor relations The process by which the corporation communicates with its investors. 314/469-3220 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion